Back to Agenda
Joint Session 1: CTIS/ CTR: 1 year into its full application
Session Chair(s)
Ruediger Pankow, DRSC
Clinical Trial Regulatory Consultant | CTIS SME, Independent Consultant, Germany
Scott Feiner
Senior Manager, Trial Disclosure, AbbVie, United States
Speaker(s)
Gerhard Schlueter, DRSC, MSC
Head of Strategic and Technical Operations, Regulatory Affairs, Bayer AG, Germany
Industry Perspective
Maria Elgaard Sørensen
Special advisor, Danish Medicines Agency, Denmark
NCAs Perspective
Guido Grass, MD
Ethic Commission, University of Cologne, Germany
Ethics Perspective
Laura Pioppo, MSC
ACT EU Programme Manager, European Medicines Agency, Netherlands
Panel discussion with Q&A with additional participation of:
Have an account?